Company / Return on Assets (ROA)
Eloxx Pharmaceuticals, Inc. Return on Assets (ROA) History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-996.1%
FY2025
5-year range
-996.1% / -15.2%
FY2021-FY2025
Trend
-896.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) changed -896% YoY in FY2025, a notable deviation from the 3-year average annual change of -407%.
Based on SEC 10-K filings.
-996.1% in FY2025 with a 10-year CAGR of -964.8%.
Declined from -31.3% to -996.1% over the past 10 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -964.8pp
Key checks
Key Insights
- Eloxx Pharmaceuticals, Inc.'s return on assets (roa) has declined for 3 consecutive years.
- In FY2025, return on assets (roa) decreased 896.2% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -40.59 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -996.1% | -896.2% |
| FY2016 | -100.0% | -219.3% |
| FY2015 | -31.3% | -106.1% |
| FY2014 | -15.2% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026